Journal article

Structure and inhibition of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus

RA North, AJA Watson, FG Pearce, AC Muscroft-Taylor, R Friemann, AJ Fairbanks, RCJ Dobson

FEBS Letters | WILEY | Published : 2016

Abstract

N-Acetylneuraminate lyase is the first committed enzyme in the degradation of sialic acid by bacterial pathogens. In this study, we analyzed the kinetic parameters of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus (MRSA). We determined that the enzyme has a relatively high KM of 3.2 mm, suggesting that flux through the catabolic pathway is likely to be controlled by this enzyme. Our data indicate that sialic acid alditol, a known inhibitor of N-acetylneuraminate lyase enzymes, is a stronger inhibitor of MRSA N-acetylneuraminate lyase than of Clostridium perfringens N-acetylneuraminate lyase. Our analysis of the crystal structure of ligand-free and 2R-sialic acid a..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Army Research Laboratory


Funding Acknowledgements

This work was supported by grants from the Ministry of Business, Innovation and Employment (contract UOCX1208 to RCJD), the New Zealand Royal Society Marsden Fund (contract UOC1013 to RCJD), and the US Army Research Laboratory and US Army Research Office (contract W911NF-11-1-0481 to RCJD). RF acknowledges the Swedish Research Council, the Swedish Research Council Formas and the Swedish Governmental Agency for Innovation Systems (VINNOVA). We especially thank Jackie Healy for her quintessential technical support.